ArticleFrontiers in oncology2021

Comprehensive Comparison Between Adjuvant Targeted Therapy and Chemotherapy for EGFR-Mutant NSCLC Patients: A Cost-Effectiveness Analysis.

Wenqian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.